nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TUBB—Vinblastine—head and neck cancer	0.45	0.526	CbGbCtD
Podofilox—TUBB—Docetaxel—head and neck cancer	0.371	0.433	CbGbCtD
Podofilox—CYP3A4—Vinblastine—head and neck cancer	0.0192	0.0224	CbGbCtD
Podofilox—CYP3A4—Docetaxel—head and neck cancer	0.0158	0.0185	CbGbCtD
Podofilox—Scab—Fluorouracil—head and neck cancer	0.0048	0.0698	CcSEcCtD
Podofilox—Application site pain—Fluorouracil—head and neck cancer	0.00347	0.0505	CcSEcCtD
Podofilox—Blister—Hydroxyurea—head and neck cancer	0.00294	0.0428	CcSEcCtD
Podofilox—Skin ulcer—Hydroxyurea—head and neck cancer	0.00273	0.0396	CcSEcCtD
Podofilox—TOP2A—G0 and Early G1—CCNA1—head and neck cancer	0.00264	0.0546	CbGpPWpGaD
Podofilox—Tenderness—Hydroxyurea—head and neck cancer	0.00243	0.0353	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 1—CCNA1—head and neck cancer	0.00234	0.0485	CbGpPWpGaD
Podofilox—Ulcer—Hydroxyurea—head and neck cancer	0.00224	0.0326	CcSEcCtD
Podofilox—Blister—Fluorouracil—head and neck cancer	0.00212	0.0308	CcSEcCtD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—head and neck cancer	0.00204	0.0421	CbGpPWpGaD
Podofilox—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00203	0.0294	CcSEcCtD
Podofilox—TOP2A—Vindesine—Vinblastine—head and neck cancer	0.0019	0.317	CbGdCrCtD
Podofilox—Tingling sensation—Fluorouracil—head and neck cancer	0.0019	0.0276	CcSEcCtD
Podofilox—Stinging—Fluorouracil—head and neck cancer	0.00189	0.0274	CcSEcCtD
Podofilox—TOP2A—Paclitaxel—Docetaxel—head and neck cancer	0.00187	0.311	CbGdCrCtD
Podofilox—TUBB—hair follicle—head and neck cancer	0.00178	0.0968	CbGeAlD
Podofilox—Tenderness—Fluorouracil—head and neck cancer	0.00175	0.0254	CcSEcCtD
Podofilox—Redness—Docetaxel—head and neck cancer	0.00163	0.0237	CcSEcCtD
Podofilox—Ulcer—Fluorouracil—head and neck cancer	0.00161	0.0235	CcSEcCtD
Podofilox—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00161	0.0234	CcSEcCtD
Podofilox—Inflammation—Fluorouracil—head and neck cancer	0.00157	0.0229	CcSEcCtD
Podofilox—Etoposide—PTGS2—head and neck cancer	0.00153	1	CrCbGaD
Podofilox—TUBA4A—G2/M Transition—CCNA1—head and neck cancer	0.00133	0.0275	CbGpPWpGaD
Podofilox—TUBA4A—parotid gland—head and neck cancer	0.00133	0.0721	CbGeAlD
Podofilox—TUBA4A—Mitotic G2-G2/M phases—CCNA1—head and neck cancer	0.00131	0.0271	CbGpPWpGaD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—head and neck cancer	0.00128	0.0265	CbGpPWpGaD
Podofilox—TUBA4A—saliva-secreting gland—head and neck cancer	0.00127	0.0691	CbGeAlD
Podofilox—Swelling—Fluorouracil—head and neck cancer	0.00126	0.0183	CcSEcCtD
Podofilox—TOP2A—Vinorelbine—Vinblastine—head and neck cancer	0.0012	0.2	CbGdCrCtD
Podofilox—Haemoglobin—Vinblastine—head and neck cancer	0.00117	0.0171	CcSEcCtD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.00117	0.0242	CbGpPWpGaD
Podofilox—Haemorrhage—Vinblastine—head and neck cancer	0.00117	0.017	CcSEcCtD
Podofilox—TUBA4A—connective tissue—head and neck cancer	0.00117	0.0635	CbGeAlD
Podofilox—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00116	0.0169	CcSEcCtD
Podofilox—Inflammation—Docetaxel—head and neck cancer	0.00114	0.0165	CcSEcCtD
Podofilox—TUBB—G2/M Transition—CCNA1—head and neck cancer	0.00113	0.0234	CbGpPWpGaD
Podofilox—TUBB—Mitotic G2-G2/M phases—CCNA1—head and neck cancer	0.00111	0.023	CbGpPWpGaD
Podofilox—TUBA4A—epithelium—head and neck cancer	0.00111	0.0603	CbGeAlD
Podofilox—Haemoglobin—Hydroxyurea—head and neck cancer	0.00107	0.0156	CcSEcCtD
Podofilox—Haemorrhage—Hydroxyurea—head and neck cancer	0.00107	0.0155	CcSEcCtD
Podofilox—Skin exfoliation—Docetaxel—head and neck cancer	0.00105	0.0153	CcSEcCtD
Podofilox—TOP2A—Vincristine—Vinblastine—head and neck cancer	0.00103	0.171	CbGdCrCtD
Podofilox—NR3C1—Nuclear Receptors—RARB—head and neck cancer	0.00102	0.0212	CbGpPWpGaD
Podofilox—Dry skin—Fluorouracil—head and neck cancer	0.00102	0.0148	CcSEcCtD
Podofilox—NR3C1—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.00101	0.0209	CbGpPWpGaD
Podofilox—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.001	0.0207	CbGpPWpGaD
Podofilox—TUBA4A—trachea—head and neck cancer	0.00098	0.0533	CbGeAlD
Podofilox—TUBB—parotid gland—head and neck cancer	0.000973	0.0529	CbGeAlD
Podofilox—TUBB—saliva-secreting gland—head and neck cancer	0.000932	0.0506	CbGeAlD
Podofilox—Erythema—Hydroxyurea—head and neck cancer	0.000928	0.0135	CcSEcCtD
Podofilox—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000912	0.0189	CbGpPWpGaD
Podofilox—Swelling—Docetaxel—head and neck cancer	0.000907	0.0132	CcSEcCtD
Podofilox—TUBA4A—lymphoid tissue—head and neck cancer	0.000854	0.0464	CbGeAlD
Podofilox—TOP2A—Gastric Cancer Network 1—NOTCH1—head and neck cancer	0.000849	0.0176	CbGpPWpGaD
Podofilox—Dermatitis bullous—Docetaxel—head and neck cancer	0.000837	0.0122	CcSEcCtD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.000808	0.0167	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000784	0.0114	CcSEcCtD
Podofilox—TUBA4A—thyroid gland—head and neck cancer	0.000776	0.0422	CbGeAlD
Podofilox—Haemoglobin—Fluorouracil—head and neck cancer	0.000771	0.0112	CcSEcCtD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—CDH1—head and neck cancer	0.00077	0.0159	CbGpPWpGaD
Podofilox—Haemorrhage—Fluorouracil—head and neck cancer	0.000767	0.0111	CcSEcCtD
Podofilox—Oedema—Hydroxyurea—head and neck cancer	0.000757	0.011	CcSEcCtD
Podofilox—Paraesthesia—Vinblastine—head and neck cancer	0.000745	0.0108	CcSEcCtD
Podofilox—Skin disorder—Hydroxyurea—head and neck cancer	0.000735	0.0107	CcSEcCtD
Podofilox—Dry skin—Docetaxel—head and neck cancer	0.000734	0.0107	CcSEcCtD
Podofilox—TUBB—trachea—head and neck cancer	0.000719	0.0391	CbGeAlD
Podofilox—Pain—Vinblastine—head and neck cancer	0.00071	0.0103	CcSEcCtD
Podofilox—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000707	0.0146	CbGpPWpGaD
Podofilox—TUBA4A—head—head and neck cancer	0.000688	0.0374	CbGeAlD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.000685	0.0142	CbGpPWpGaD
Podofilox—Erythema—Fluorouracil—head and neck cancer	0.000668	0.0097	CcSEcCtD
Podofilox—TUBB—Pathogenic Escherichia coli infection—CDH1—head and neck cancer	0.000655	0.0136	CbGpPWpGaD
Podofilox—Pain—Hydroxyurea—head and neck cancer	0.000647	0.00941	CcSEcCtD
Podofilox—TUBA4A—Parkin-Ubiquitin Proteasomal System pathway—CASP8—head and neck cancer	0.000642	0.0133	CbGpPWpGaD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—head and neck cancer	0.000577	0.0119	CbGpPWpGaD
Podofilox—TOP2A—thyroid gland—head and neck cancer	0.000574	0.0312	CbGeAlD
Podofilox—TUBB—thyroid gland—head and neck cancer	0.000568	0.0309	CbGeAlD
Podofilox—Haemoglobin—Docetaxel—head and neck cancer	0.000556	0.00809	CcSEcCtD
Podofilox—Haemorrhage—Docetaxel—head and neck cancer	0.000554	0.00805	CcSEcCtD
Podofilox—NR3C1—neck—head and neck cancer	0.000553	0.0301	CbGeAlD
Podofilox—Dizziness—Vinblastine—head and neck cancer	0.000549	0.00798	CcSEcCtD
Podofilox—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000548	0.0113	CbGpPWpGaD
Podofilox—TUBB—Parkin-Ubiquitin Proteasomal System pathway—CASP8—head and neck cancer	0.000546	0.0113	CbGpPWpGaD
Podofilox—Oedema—Fluorouracil—head and neck cancer	0.000545	0.00792	CcSEcCtD
Podofilox—Vomiting—Vinblastine—head and neck cancer	0.000528	0.00767	CcSEcCtD
Podofilox—Headache—Vinblastine—head and neck cancer	0.00052	0.00756	CcSEcCtD
Podofilox—Dizziness—Hydroxyurea—head and neck cancer	0.000501	0.00728	CcSEcCtD
Podofilox—Immune system disorder—Docetaxel—head and neck cancer	0.0005	0.00727	CcSEcCtD
Podofilox—Insomnia—Fluorouracil—head and neck cancer	0.000493	0.00716	CcSEcCtD
Podofilox—NR3C1—Adipogenesis—CEBPA—head and neck cancer	0.000491	0.0102	CbGpPWpGaD
Podofilox—Paraesthesia—Fluorouracil—head and neck cancer	0.000489	0.00711	CcSEcCtD
Podofilox—Erythema—Docetaxel—head and neck cancer	0.000482	0.007	CcSEcCtD
Podofilox—TUBA4A—lymph node—head and neck cancer	0.000482	0.0262	CbGeAlD
Podofilox—Vomiting—Hydroxyurea—head and neck cancer	0.000481	0.007	CcSEcCtD
Podofilox—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000481	0.00996	CbGpPWpGaD
Podofilox—Rash—Hydroxyurea—head and neck cancer	0.000477	0.00694	CcSEcCtD
Podofilox—Dermatitis—Hydroxyurea—head and neck cancer	0.000477	0.00693	CcSEcCtD
Podofilox—Headache—Hydroxyurea—head and neck cancer	0.000474	0.00689	CcSEcCtD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.00047	0.00972	CbGpPWpGaD
Podofilox—Pain—Fluorouracil—head and neck cancer	0.000466	0.00677	CcSEcCtD
Podofilox—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000463	0.00958	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000458	0.00949	CbGpPWpGaD
Podofilox—NR3C1—parotid gland—head and neck cancer	0.000451	0.0245	CbGeAlD
Podofilox—NR3C1—saliva-secreting gland—head and neck cancer	0.000432	0.0235	CbGeAlD
Podofilox—TOP2A—Gastric Cancer Network 2—EGFR—head and neck cancer	0.000424	0.00877	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.000422	0.00874	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000417	0.00863	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000407	0.00592	CcSEcCtD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—head and neck cancer	0.000404	0.00836	CbGpPWpGaD
Podofilox—NR3C1—connective tissue—head and neck cancer	0.000397	0.0216	CbGeAlD
Podofilox—Oedema—Docetaxel—head and neck cancer	0.000393	0.00572	CcSEcCtD
Podofilox—NR3C1—Adipogenesis—STAT6—head and neck cancer	0.000393	0.00813	CbGpPWpGaD
Podofilox—Pruritus—Fluorouracil—head and neck cancer	0.000386	0.0056	CcSEcCtD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—head and neck cancer	0.000384	0.00795	CbGpPWpGaD
Podofilox—Skin disorder—Docetaxel—head and neck cancer	0.000382	0.00555	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—CCNA1—head and neck cancer	0.000378	0.00782	CbGpPWpGaD
Podofilox—NR3C1—epithelium—head and neck cancer	0.000377	0.0205	CbGeAlD
Podofilox—TUBA4A—Platelet degranulation—VEGFA—head and neck cancer	0.000371	0.00767	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00037	0.00766	CbGpPWpGaD
Podofilox—Dizziness—Fluorouracil—head and neck cancer	0.00036	0.00524	CcSEcCtD
Podofilox—TUBB—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.000359	0.00743	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000358	0.0074	CbGpPWpGaD
Podofilox—TOP2A—lymph node—head and neck cancer	0.000356	0.0194	CbGeAlD
Podofilox—Insomnia—Docetaxel—head and neck cancer	0.000356	0.00517	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 2—TP53—head and neck cancer	0.000356	0.00736	CbGpPWpGaD
Podofilox—Paraesthesia—Docetaxel—head and neck cancer	0.000353	0.00513	CcSEcCtD
Podofilox—TUBB—lymph node—head and neck cancer	0.000353	0.0192	CbGeAlD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000353	0.00731	CbGpPWpGaD
Podofilox—Vomiting—Fluorouracil—head and neck cancer	0.000346	0.00504	CcSEcCtD
Podofilox—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000346	0.00716	CbGpPWpGaD
Podofilox—Rash—Fluorouracil—head and neck cancer	0.000344	0.00499	CcSEcCtD
Podofilox—Dermatitis—Fluorouracil—head and neck cancer	0.000343	0.00499	CcSEcCtD
Podofilox—Headache—Fluorouracil—head and neck cancer	0.000341	0.00496	CcSEcCtD
Podofilox—Pain—Docetaxel—head and neck cancer	0.000336	0.00489	CcSEcCtD
Podofilox—NR3C1—trachea—head and neck cancer	0.000333	0.0181	CbGeAlD
Podofilox—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000332	0.00688	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—TYMS—head and neck cancer	0.00033	0.00684	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCNA1—head and neck cancer	0.000321	0.00665	CbGpPWpGaD
Podofilox—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000315	0.00652	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—RAD51—head and neck cancer	0.000303	0.00628	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—GRP—head and neck cancer	0.000294	0.00609	CbGpPWpGaD
Podofilox—NR3C1—lymphoid tissue—head and neck cancer	0.00029	0.0158	CbGeAlD
Podofilox—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000289	0.00599	CbGpPWpGaD
Podofilox—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000278	0.00576	CbGpPWpGaD
Podofilox—Pruritus—Docetaxel—head and neck cancer	0.000278	0.00404	CcSEcCtD
Podofilox—NR3C1—thyroid gland—head and neck cancer	0.000263	0.0143	CbGeAlD
Podofilox—NR3C1—Endoderm Differentiation—NOTCH1—head and neck cancer	0.000263	0.00545	CbGpPWpGaD
Podofilox—Dizziness—Docetaxel—head and neck cancer	0.00026	0.00378	CcSEcCtD
Podofilox—TUBB—Cell Cycle—RAD51—head and neck cancer	0.000258	0.00534	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.000251	0.0052	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00025	0.00518	CbGpPWpGaD
Podofilox—Vomiting—Docetaxel—head and neck cancer	0.00025	0.00363	CcSEcCtD
Podofilox—Rash—Docetaxel—head and neck cancer	0.000248	0.0036	CcSEcCtD
Podofilox—Dermatitis—Docetaxel—head and neck cancer	0.000248	0.0036	CcSEcCtD
Podofilox—Headache—Docetaxel—head and neck cancer	0.000246	0.00358	CcSEcCtD
Podofilox—TOP2A—Circadian rythm related genes—TYMS—head and neck cancer	0.00024	0.00498	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000236	0.0049	CbGpPWpGaD
Podofilox—NR3C1—head—head and neck cancer	0.000234	0.0127	CbGeAlD
Podofilox—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000234	0.00484	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000231	0.00479	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCNA1—head and neck cancer	0.000225	0.00465	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—TYMS—head and neck cancer	0.000204	0.00422	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.0002	0.00414	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000197	0.00408	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000193	0.00401	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000184	0.00381	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TYMS—head and neck cancer	0.000182	0.00377	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000181	0.00375	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—RAD51—head and neck cancer	0.00018	0.00374	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.000177	0.00366	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—TYMS—head and neck cancer	0.000173	0.00359	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000172	0.00357	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000171	0.00354	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000166	0.00345	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CCND1—head and neck cancer	0.000166	0.00344	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000164	0.0034	CbGpPWpGaD
Podofilox—NR3C1—lymph node—head and neck cancer	0.000164	0.00889	CbGeAlD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000162	0.00335	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.000156	0.00323	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	0.000156	0.00322	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000156	0.00322	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TYMS—head and neck cancer	0.000155	0.00321	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000149	0.00308	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000148	0.00306	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000147	0.00304	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.00014	0.00289	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.00014	0.00289	CbGpPWpGaD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000139	0.00288	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000138	0.00285	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.000128	0.00266	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000127	0.00263	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000126	0.00261	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000125	0.00259	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000122	0.00252	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—TYMS—head and neck cancer	0.000121	0.00251	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00012	0.00249	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.000119	0.00247	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000119	0.00246	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—PTEN—head and neck cancer	0.000117	0.00242	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.000114	0.00235	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000111	0.00229	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.00011	0.00227	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000109	0.00226	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TYMS—head and neck cancer	0.000108	0.00224	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	0.000105	0.00217	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000104	0.00215	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND1—head and neck cancer	0.000103	0.00212	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.0001	0.00207	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IL2—head and neck cancer	9.97e-05	0.00206	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	9.89e-05	0.00205	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	9.89e-05	0.00205	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.74e-05	0.00202	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCND1—head and neck cancer	9.17e-05	0.0019	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	9.08e-05	0.00188	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—STAT3—head and neck cancer	9.07e-05	0.00188	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	8.95e-05	0.00185	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND1—head and neck cancer	8.72e-05	0.00181	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	8.61e-05	0.00178	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	8.58e-05	0.00178	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	8.54e-05	0.00177	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	8.49e-05	0.00176	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—head and neck cancer	8.48e-05	0.00175	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	8.46e-05	0.00175	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	8.45e-05	0.00175	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	8.3e-05	0.00172	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	8.05e-05	0.00167	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK3—head and neck cancer	8.02e-05	0.00166	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—head and neck cancer	7.97e-05	0.00165	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	7.92e-05	0.00164	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND1—head and neck cancer	7.8e-05	0.00162	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK1—head and neck cancer	7.63e-05	0.00158	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—UROD—head and neck cancer	7.57e-05	0.00157	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK3—head and neck cancer	7.57e-05	0.00157	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK1—head and neck cancer	7.2e-05	0.00149	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK3—head and neck cancer	7.2e-05	0.00149	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	7.01e-05	0.00145	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK1—head and neck cancer	6.85e-05	0.00142	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RARB—head and neck cancer	6.72e-05	0.00139	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CA—head and neck cancer	6.62e-05	0.00137	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK3—head and neck cancer	6.43e-05	0.00133	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—head and neck cancer	6.4e-05	0.00133	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HRAS—head and neck cancer	6.12e-05	0.00127	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK1—head and neck cancer	6.12e-05	0.00127	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—YAP1—head and neck cancer	6.11e-05	0.00127	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—head and neck cancer	6.1e-05	0.00126	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—head and neck cancer	6.04e-05	0.00125	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.87e-05	0.00122	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	5.72e-05	0.00118	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.46e-05	0.00113	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—head and neck cancer	5.46e-05	0.00113	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—head and neck cancer	5.41e-05	0.00112	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	5.38e-05	0.00111	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	5.18e-05	0.00107	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—head and neck cancer	5.14e-05	0.00106	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	5.1e-05	0.00106	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	5.03e-05	0.00104	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	4.79e-05	0.000991	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UROD—head and neck cancer	4.55e-05	0.000942	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK3—head and neck cancer	4.5e-05	0.000932	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK1—head and neck cancer	4.28e-05	0.000886	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—head and neck cancer	3.59e-05	0.000744	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.34e-05	0.000691	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.3e-05	0.000684	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NAT2—head and neck cancer	3.14e-05	0.000651	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—DPYD—head and neck cancer	2.76e-05	0.000571	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH1—head and neck cancer	2.75e-05	0.00057	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—YAP1—head and neck cancer	2.62e-05	0.000541	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.97e-05	0.000407	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NAT2—head and neck cancer	1.89e-05	0.000391	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.71e-05	0.000355	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—DPYD—head and neck cancer	1.66e-05	0.000343	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—YAP1—head and neck cancer	1.57e-05	0.000326	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TYMS—head and neck cancer	1.57e-05	0.000325	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.55e-05	0.000321	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MAPK3—head and neck cancer	1.52e-05	0.000315	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPX1—head and neck cancer	1.49e-05	0.000308	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.47e-05	0.000305	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.21e-05	0.00025	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—head and neck cancer	1.03e-05	0.000213	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TYMS—head and neck cancer	9.44e-06	0.000196	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—head and neck cancer	9.34e-06	0.000193	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPX1—head and neck cancer	8.94e-06	0.000185	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1A1—head and neck cancer	8.85e-06	0.000183	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—head and neck cancer	8.75e-06	0.000181	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTEN—head and neck cancer	7.63e-06	0.000158	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—head and neck cancer	5.38e-06	0.000111	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.26e-06	0.000109	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTEN—head and neck cancer	4.59e-06	9.5e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—head and neck cancer	4.4e-06	9.11e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.24e-06	6.7e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—head and neck cancer	2.65e-06	5.48e-05	CbGpPWpGaD
